rs7983722

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_016529.6(ATP8A2):​c.3183+8603G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0532 in 151,644 control chromosomes in the GnomAD database, including 542 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.053 ( 542 hom., cov: 32)

Consequence

ATP8A2
NM_016529.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.92

Publications

2 publications found
Variant links:
Genes affected
ATP8A2 (HGNC:13533): (ATPase phospholipid transporting 8A2) The protein encoded by this gene is a member of the P4 ATPase family of proteins, which are thought to be involved in a process called lipid flipping, whereby phospholipids are translocated inwards from the exoplasmic leaflet to the cytosolic leaflet of the cell membrane, which aids in generating and maintaining asymmetry in membrane lipids. This protein is predicted to contain an E1 E2 ATPase, a haloacid dehalogenase-like hydrolase (HAD) domain, and multiple transmembrane domains. Associations between this protein and cell cycle control protein 50A are important for translocation of phosphatidylserine across membranes. Mutations in this gene have been associated with a syndrome (CAMRQ4) characterized by cerebellar ataxia and cognitive disabilities. In addition, a translocation breakpoint within this gene was observed in an individual with neurological dysfunction. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2017]
ATP8A2 Gene-Disease associations (from GenCC):
  • cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 4
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • cerebellar ataxia, intellectual disability, and dysequilibrium
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.132 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016529.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP8A2
NM_016529.6
MANE Select
c.3183+8603G>A
intron
N/ANP_057613.4
ATP8A2
NM_001411005.1
c.3108+8603G>A
intron
N/ANP_001397934.1
ATP8A2
NM_001313741.1
c.2988+8603G>A
intron
N/ANP_001300670.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP8A2
ENST00000381655.7
TSL:1 MANE Select
c.3183+8603G>A
intron
N/AENSP00000371070.2
ATP8A2
ENST00000281620.11
TSL:1
n.*3001+8603G>A
intron
N/AENSP00000281620.7
ATP8A2
ENST00000491840.1
TSL:1
n.2054+8603G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0529
AC:
8022
AN:
151544
Hom.:
532
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.135
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.128
Gnomad ASJ
AF:
0.0101
Gnomad EAS
AF:
0.0230
Gnomad SAS
AF:
0.0141
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00230
Gnomad OTH
AF:
0.0616
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0532
AC:
8071
AN:
151644
Hom.:
542
Cov.:
32
AF XY:
0.0538
AC XY:
3982
AN XY:
74024
show subpopulations
African (AFR)
AF:
0.135
AC:
5588
AN:
41328
American (AMR)
AF:
0.129
AC:
1973
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.0101
AC:
35
AN:
3468
East Asian (EAS)
AF:
0.0231
AC:
119
AN:
5150
South Asian (SAS)
AF:
0.0140
AC:
67
AN:
4798
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10400
Middle Eastern (MID)
AF:
0.0137
AC:
4
AN:
292
European-Non Finnish (NFE)
AF:
0.00230
AC:
156
AN:
67954
Other (OTH)
AF:
0.0615
AC:
129
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
344
688
1033
1377
1721
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0260
Hom.:
345
Bravo
AF:
0.0701
Asia WGS
AF:
0.0420
AC:
145
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.033
DANN
Benign
0.73
PhyloP100
-2.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7983722; hg19: chr13-26445149; COSMIC: COSV54943210; API